No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
Satellos Bioscience Raises $57 Million in Public Offering
Satellos Priced US$40 Million Overnight Marketed Public Offering
Satellos Doses First Participant With Duchenne Muscular Dystrophy in Phase 1b Trial
Satellos to Participate in Oppenheimer Movers in Rare Disease Summit
Satellos to Participate in Duchenne KOL Investor Webinar on December 4, 2024